One platform connecting startups, corporations, research institutions, regions and investors
Southeast Asia Innovation Landscape 2026
ESG Data-as-a-Service (DaaS) A game-changer for resource-constrained SMEs
1. Technology overview
Oxford Nanopore Technologies is a British life sciences company spun out from the University of Oxford in 2005, headquartered at the Oxford Science Park. It was founded to make nanopore-based DNA and RNA sequencing available directly to laboratories, replacing methods that required large centralized facilities.
The company sells sequencing devices ranging from the portable MinION to the high-throughput GridION and PromethION systems, together with library preparation kits and the EPI2ME software platform for analysing sequencing data. Customers include research institutes, biopharmaceutical companies, and clinical laboratories working in human genomics, oncology, infectious disease, and microbiology; the company listed on the London Stock Exchange in 2021.
2. Highlighted features & specifications
1. MinION: portable nanopore sequencing device for field and lab use.
2. GridION and PromethION: high-throughput sequencing systems for large-scale projects.
3. EPI2ME: cloud software platform for sequencing data analysis.
4. Library preparation kits and workflow automation tools.
5. Applications across cancer research, infectious disease, and human genomics.
6. Listed on the London Stock Exchange in 2021; received the 2026 MacRobert Award.
